
U.S. Indicts Two Indians in Counterfeit Ozempic Smuggling Scheme
The story in brief
Two Indian nationals were indicted by a federal grand jury for smuggling and selling counterfeit Ozempic, despite FDA seizures in December 2023. One defendant pleaded not guilty after extradition from Italy, while the other remains at large. The counterfeit drugs, obtained in China, were sold at discounted prices with fake packaging.